EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Lipid-Based Self-Microemulsion of Niclosamide Achieved Enhanced Oral Delivery and Anti-Tumor Efficacy in Orthotopic Patient-Derived Xenograft of Hepatocellular Carcinoma in Mice

Yi Liu iD, David Quintanar Guerrero, David Lechuga-Ballesteros, Mingdian Tan, Faiz Ahmad, Bilal Aleiwi, Edmund Lee Ellsworth, Bin Chen, Mei-Sze Chua iD, Samuel So

International Journal of Nanomedicine · 2024

DOI: 10.2147/ijn.s442143 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024. Verfasst von Yi Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, School of Medicine, Stanford University, Stanford, CA, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansMiceAnimalsNiclosamideHeterograftsEmulsionsDrug Delivery SystemsSolubilityBiological AvailabilityWaterLipidsAdministration, Oral

Stichwörter der Autor:innen

SMEDDSdrug repurposinghepatocellular carcinomaniclosamideoral bioavailabilityself-microemulsifying drug delivery system

Substanzen

NiclosamideEmulsionsWaterLipids

Autor:innen und Institutionen

  • Department of Surgery, School of Medicine, Stanford University, Stanford, CA, USA.
  • Laboratorio de Investigación y Posgrado en Tecnologías Farmacéuticas, Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Cuautitlán Izcalli, CP, 54745, Mexico.
  • AstraZeneca Pharmaceuticals, Ltd. 4222 Emperor Boulevard, Durham, NC, USA.
  • Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI, USA.

ORCID-Profile: Yi Liu, Mei-Sze Chua

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Liu, Y., Guerrero, D. Q., Lechuga-Ballesteros, D., Tan, M., Ahmad, F., Aleiwi, B., Ellsworth, E. L., Chen, B., Chua, M. S., & So, S. (2024). Lipid-Based Self-Microemulsion of Niclosamide Achieved Enhanced Oral Delivery and Anti-Tumor Efficacy in Orthotopic Patient-Derived Xenograft of Hepatocellular Carcinoma in Mice. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s442143

Vancouver

Liu Y, Guerrero DQ, Lechuga-Ballesteros D, Tan M, Ahmad F, Aleiwi B, et al. Lipid-Based Self-Microemulsion of Niclosamide Achieved Enhanced Oral Delivery and Anti-Tumor Efficacy in Orthotopic Patient-Derived Xenograft of Hepatocellular Carcinoma in Mice. International Journal of Nanomedicine. 2024. doi:10.2147/ijn.s442143

BibTeX
@article{Liu2024,
  author = {Liu, Yi and Guerrero, David Quintanar and Lechuga-Ballesteros, David and Tan, Mingdian and Ahmad, Faiz and Aleiwi, Bilal and Ellsworth, Edmund Lee and Chen, Bin and Chua, Mei-Sze and So, Samuel},
  title = {Lipid-Based Self-Microemulsion of Niclosamide Achieved Enhanced Oral Delivery and Anti-Tumor Efficacy in Orthotopic Patient-Derived Xenograft of Hepatocellular Carcinoma in Mice},
  journal = {International Journal of Nanomedicine},
  year = {2024},
  doi = {10.2147/ijn.s442143}
}
Kostenlos starten →